PLSE - Pulse Biosciences Inc logo

Pulse Biosciences Inc

PLSE

Pulse Biosciences develops and commercializes medical devices using Nano-Pulse Electro-Signaling technology. Its products include systems for soft tissue and cardiac ablation, ensuring targeted treatments for benign skin lesions and surgical applications.

โš•๏ธ Healthcare NASDAQ Listed 2016 $ USD
$1,000 invested 10 years ago โ†’$8,831today

Score Overview

1 Year
Score
Net Growth-10.00%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth238.57%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.7
Net Growth-26.75%
Net Trend40%
Net Income Consistencyโ€”
Rev Growth-16.43%
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-6x
Net Trend20%
Net Income Consistency
Rev Growth17x
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth-6x
Net Trend20%
Net Income Consistency
Rev Growth17x
Rev Trend60%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Pulse Biosciences Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 10 years of fundamentals. PLSE does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-21
$ 51.31โ€”
1 Year2025-10-21
$ 18.08183.79%
5 Years2021-10-21
$ 22.35129.57%
10 Years2016-10-21
$ 5.818x
All Time2016-05-18
$ 4.1712x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 1M-$ 80M$ 101M
2025$ 350K-$ 72M$ 80M
2024$ 0.00-$ 53M$ 118M
2023-$ 9K-$ 42M$ 44M
2022$ 700K-$ 58M$ 61M
2021$ 1M-$ 63M$ 28M
2020$ 114K-$ 49M$ 20M
2019$ 0.00-$ 45M$ 25M
2018$ 0.00-$ 37M$ 59M
2017$ 247K-$ 25M$ 38M
IPO2016$ 68K-$ 9M$ 16M
PLSE - Pulse Biosciences Inc logo

Pulse Biosciences Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 114K to $ 350K and net income went from -$ 49M to -$ 72M. Revenue increased in 3 of those 5 years; net income in 2.

Across Pulse Biosciences Inc's full reported history, from 2016 to 2025, revenue grew from $ 68K to $ 350K and net income went from -$ 9M to -$ 72M. Revenue increased in 60% of the years measured; net income in 20%.

Pulse Biosciences Inc currently holds a 5-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.

Membership

Explore PLSE with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,118 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies